GTG.AX
Price:
$0.039
Market Cap:
$9.45M
Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1988-01-31
Stock Exchange
ASX
Ticker
GTG.AX
According to Genetic Technologies Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.88. This represents a change of 38.10% compared to the average of 0.64 of the last 4 quarters.
The mean historical Current Ratio of Genetic Technologies Limited over the last ten years is 6.92. The current 0.88 Current Ratio has changed 1.17% with respect to the historical average. Over the past ten years (40 quarters), GTG.AX's Current Ratio was at its highest in in the March 2021 quarter at 15.82. The Current Ratio was at its lowest in in the March 2012 quarter at 0.
Average
6.92
Median
6.03
Minimum
0.88
Maximum
15.82
Discovering the peaks and valleys of Genetic Technologies Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 499.44%
Maximum Annual Current Ratio = 15.82
Minimum Annual Increase = -75.60%
Minimum Annual Current Ratio = 0.88
Year | Current Ratio | Change |
---|---|---|
2024 | 0.88 | -72.21% |
2023 | 3.17 | -17.91% |
2022 | 3.86 | -75.60% |
2021 | 15.82 | 45.55% |
2020 | 10.87 | 407.88% |
2019 | 2.14 | -48.17% |
2018 | 4.13 | -47.98% |
2017 | 7.94 | -12.83% |
2016 | 9.11 | -19.25% |
2015 | 11.28 | 499.44% |
The current Current Ratio of Genetic Technologies Limited (GTG.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.64
5-year avg
6.92
10-year avg
6.92
Genetic Technologies Limited’s Current Ratio is less than IDT Australia Limited (1.34), less than Antisense Therapeutics Limited (0), greater than Biotron Limited (0.58), less than Bionomics Limited (3.30), less than Patrys Limited (5.53),
Company | Current Ratio | Market cap |
---|---|---|
1.34 | $46.49M | |
0 | $52.29M | |
0.58 | $15.34M | |
3.30 | $13.22M | |
5.53 | $6.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Technologies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genetic Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Genetic Technologies Limited's Current Ratio?
How is the Current Ratio calculated for Genetic Technologies Limited (GTG.AX)?
What is the highest Current Ratio for Genetic Technologies Limited (GTG.AX)?
What is the 3-year average Current Ratio for Genetic Technologies Limited (GTG.AX)?
What is the 5-year average Current Ratio for Genetic Technologies Limited (GTG.AX)?
How does the current Current Ratio for Genetic Technologies Limited (GTG.AX) compare to its historical average?